Compile Data Set for Download or QSAR
Report error Found 132 Enz. Inhib. hit(s) with all data for entry = 50000976
TargetLysyl oxidase homolog 2(Human)
Pharmakea Therapeutics

Curated by ChEMBL
LigandPNGBDBM50266796(CHEMBL4068580)
Affinity DataIC50: 34nMAssay Description:Inhibition of human LOXL2 expressed in CHO cells assessed as reduction of H2O2 production from oxidative deamination of DAP preincubated for 2 hrs fo...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLysyl oxidase homolog 2(Human)
Pharmakea Therapeutics

Curated by ChEMBL
LigandPNGBDBM50266838(CHEMBL4084982)
Affinity DataIC50: 35nMAssay Description:Inhibition of human LOXL2 expressed in CHO cells assessed as reduction of H2O2 production from oxidative deamination of DAP preincubated for 2 hrs fo...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLysyl oxidase homolog 2(Human)
Pharmakea Therapeutics

Curated by ChEMBL
LigandPNGBDBM50266824(CHEMBL4082808)
Affinity DataIC50: 43nMAssay Description:Inhibition of human LOXL2 expressed in CHO cells assessed as reduction of H2O2 production from oxidative deamination of DAP preincubated for 2 hrs fo...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLysyl oxidase homolog 2(Human)
Pharmakea Therapeutics

Curated by ChEMBL
LigandPNGBDBM50266783(CHEMBL4086010)
Affinity DataIC50: 50nMAssay Description:Inhibition of human LOXL2 expressed in CHO cells assessed as reduction of H2O2 production from oxidative deamination of DAP preincubated for 2 hrs fo...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLysyl oxidase homolog 2(Human)
Pharmakea Therapeutics

Curated by ChEMBL
LigandPNGBDBM50266784(CHEMBL4103928)
Affinity DataIC50: 53nMAssay Description:Inhibition of human LOXL2 expressed in CHO cells assessed as reduction of H2O2 production from oxidative deamination of DAP preincubated for 2 hrs fo...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLysyl oxidase homolog 2(Human)
Pharmakea Therapeutics

Curated by ChEMBL
LigandPNGBDBM50266789(CHEMBL4088453)
Affinity DataIC50: 56nMAssay Description:Inhibition of human LOXL2 expressed in CHO cells assessed as reduction of H2O2 production from oxidative deamination of DAP preincubated for 2 hrs fo...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLysyl oxidase homolog 2(Human)
Pharmakea Therapeutics

Curated by ChEMBL
LigandPNGBDBM50266823(CHEMBL4097435)
Affinity DataIC50: 58nMAssay Description:Inhibition of human LOXL2 expressed in CHO cells assessed as reduction of H2O2 production from oxidative deamination of DAP preincubated for 2 hrs fo...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLysyl oxidase homolog 2(Human)
Pharmakea Therapeutics

Curated by ChEMBL
LigandPNGBDBM50266811(CHEMBL4059919)
Affinity DataIC50: 62nMAssay Description:Inhibition of human LOXL2 expressed in CHO cells assessed as reduction of H2O2 production from oxidative deamination of DAP preincubated for 2 hrs fo...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLysyl oxidase homolog 2(Human)
Pharmakea Therapeutics

Curated by ChEMBL
LigandPNGBDBM50266788(CHEMBL4067192)
Affinity DataIC50: 62nMAssay Description:Inhibition of human LOXL2 expressed in CHO cells assessed as reduction of H2O2 production from oxidative deamination of DAP preincubated for 2 hrs fo...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLysyl oxidase homolog 2(Human)
Pharmakea Therapeutics

Curated by ChEMBL
LigandPNGBDBM50266838(CHEMBL4084982)
Affinity DataIC50: 62nMAssay Description:Inhibition of human LOXL2 expressed in CHO cells assessed as reduction of H2O2 production from oxidative deamination of DAP preincubated for 2 hrs fo...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLysyl oxidase homolog 2(Human)
Pharmakea Therapeutics

Curated by ChEMBL
LigandPNGBDBM50266788(CHEMBL4067192)
Affinity DataIC50: 62nMAssay Description:Inhibition of human LOXL2 expressed in CHO cells assessed as reduction of H2O2 production from oxidative deamination of DAP preincubated for 2 hrs fo...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLysyl oxidase homolog 2(Human)
Pharmakea Therapeutics

Curated by ChEMBL
LigandPNGBDBM50266811(CHEMBL4059919)
Affinity DataIC50: 62nMAssay Description:Inhibition of human LOXL2 expressed in CHO cells assessed as reduction of H2O2 production from oxidative deamination of DAP preincubated for 2 hrs fo...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLysyl oxidase homolog 2(Human)
Pharmakea Therapeutics

Curated by ChEMBL
LigandPNGBDBM50232678(CHEBI:27413 | CHEMBL1618272 | US10717734, Compound...)
Affinity DataIC50: 66nMAssay Description:Inhibition of human LOXL2 expressed in CHO cells assessed as reduction of H2O2 production from oxidative deamination of DAP preincubated for 2 hrs fo...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLysyl oxidase homolog 2(Human)
Pharmakea Therapeutics

Curated by ChEMBL
LigandPNGBDBM50266840(CHEMBL4089707 | US11072585, Example 56)
Affinity DataIC50: 67nMAssay Description:Inhibition of human LOXL2 expressed in CHO cells assessed as reduction of H2O2 production from oxidative deamination of DAP preincubated for 2 hrs fo...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLysyl oxidase homolog 2(Human)
Pharmakea Therapeutics

Curated by ChEMBL
LigandPNGBDBM50266786(CHEMBL4063337)
Affinity DataIC50: 74nMAssay Description:Inhibition of human LOXL2 expressed in CHO cells assessed as reduction of H2O2 production from oxidative deamination of DAP preincubated for 2 hrs fo...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLysyl oxidase homolog 2(Human)
Pharmakea Therapeutics

Curated by ChEMBL
LigandPNGBDBM50266837(CHEMBL4100783)
Affinity DataIC50: 77nMAssay Description:Inhibition of human LOXL2 expressed in CHO cells assessed as reduction of H2O2 production from oxidative deamination of DAP preincubated for 2 hrs fo...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLysyl oxidase homolog 2(Human)
Pharmakea Therapeutics

Curated by ChEMBL
LigandPNGBDBM50266822(CHEMBL4079398)
Affinity DataIC50: 78nMAssay Description:Inhibition of human LOXL2 expressed in CHO cells assessed as reduction of H2O2 production from oxidative deamination of DAP preincubated for 2 hrs fo...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLysyl oxidase homolog 2(Human)
Pharmakea Therapeutics

Curated by ChEMBL
LigandPNGBDBM50266824(CHEMBL4082808)
Affinity DataIC50: 80nMAssay Description:Inhibition of human LOXL2 expressed in CHO cells assessed as reduction of H2O2 production from oxidative deamination of DAP preincubated for 2 hrs fo...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLysyl oxidase homolog 2(Human)
Pharmakea Therapeutics

Curated by ChEMBL
LigandPNGBDBM50266795(CHEMBL4063420)
Affinity DataIC50: 81nMAssay Description:Inhibition of human LOXL2 expressed in CHO cells assessed as reduction of H2O2 production from oxidative deamination of DAP preincubated for 2 hrs fo...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLysyl oxidase homolog 2(Human)
Pharmakea Therapeutics

Curated by ChEMBL
LigandPNGBDBM50266795(CHEMBL4063420)
Affinity DataIC50: 81nMAssay Description:Inhibition of human LOXL2 expressed in CHO cells assessed as reduction of H2O2 production from oxidative deamination of DAP preincubated for 2 hrs fo...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLysyl oxidase homolog 2(Human)
Pharmakea Therapeutics

Curated by ChEMBL
LigandPNGBDBM50266787(CHEMBL4092740)
Affinity DataIC50: 82nMAssay Description:Inhibition of human LOXL2 expressed in CHO cells assessed as reduction of H2O2 production from oxidative deamination of DAP preincubated for 2 hrs fo...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLysyl oxidase homolog 2(Human)
Pharmakea Therapeutics

Curated by ChEMBL
LigandPNGBDBM50232678(CHEBI:27413 | CHEMBL1618272 | US10717734, Compound...)
Affinity DataIC50: 83nMAssay Description:Inhibition of human LOXL2 expressed in CHO cells assessed as reduction of H2O2 production from oxidative deamination of DAP preincubated for 2 hrs fo...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLysyl oxidase homolog 2(Human)
Pharmakea Therapeutics

Curated by ChEMBL
LigandPNGBDBM50266837(CHEMBL4100783)
Affinity DataIC50: 88nMAssay Description:Inhibition of human LOXL2 expressed in CHO cells assessed as reduction of H2O2 production from oxidative deamination of DAP preincubated for 2 hrs fo...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLysyl oxidase homolog 2(Human)
Pharmakea Therapeutics

Curated by ChEMBL
LigandPNGBDBM50266826(CHEMBL4105137)
Affinity DataIC50: 96nMAssay Description:Inhibition of human LOXL2 expressed in CHO cells assessed as reduction of H2O2 production from oxidative deamination of DAP preincubated for 2 hrs fo...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLysyl oxidase homolog 2(Human)
Pharmakea Therapeutics

Curated by ChEMBL
LigandPNGBDBM50266796(CHEMBL4068580)
Affinity DataIC50: 100nMAssay Description:Inhibition of human LOXL2 expressed in CHO cells assessed as reduction of H2O2 production from oxidative deamination of DAP preincubated for 2 hrs fo...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLysyl oxidase homolog 2(Human)
Pharmakea Therapeutics

Curated by ChEMBL
LigandPNGBDBM50266822(CHEMBL4079398)
Affinity DataIC50: 100nMAssay Description:Inhibition of human LOXL2 expressed in CHO cells assessed as reduction of H2O2 production from oxidative deamination of DAP preincubated for 2 hrs fo...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLysyl oxidase homolog 2(Human)
Pharmakea Therapeutics

Curated by ChEMBL
LigandPNGBDBM50266823(CHEMBL4097435)
Affinity DataIC50: 100nMAssay Description:Inhibition of human LOXL2 expressed in CHO cells assessed as reduction of H2O2 production from oxidative deamination of DAP preincubated for 2 hrs fo...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLysyl oxidase homolog 2(Mouse)
Pharmakea Therapeutics

Curated by ChEMBL
LigandPNGBDBM50266786(CHEMBL4063337)
Affinity DataIC50: 100nMAssay Description:Inhibition of recombinant mouse LOXL2 expressed in mouse whole blood assessed as reduction of H2O2 production from oxidative deamination of DAP prein...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLysyl oxidase homolog 2(Human)
Pharmakea Therapeutics

Curated by ChEMBL
LigandPNGBDBM50266823(CHEMBL4097435)
Affinity DataIC50: 100nMAssay Description:Inhibition of human LOXL2 expressed in CHO cells assessed as reduction of H2O2 production from oxidative deamination of DAP preincubated for 2 hrs fo...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLysyl oxidase homolog 2(Human)
Pharmakea Therapeutics

Curated by ChEMBL
LigandPNGBDBM50266786(CHEMBL4063337)
Affinity DataIC50: 110nMAssay Description:Inhibition of human LOXL2 expressed in CHO cells assessed as reduction of H2O2 production from oxidative deamination of DAP preincubated for 2 hrs fo...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLysyl oxidase homolog 2(Human)
Pharmakea Therapeutics

Curated by ChEMBL
LigandPNGBDBM50266839(CHEMBL4071963)
Affinity DataIC50: 110nMAssay Description:Inhibition of human LOXL2 expressed in CHO cells assessed as reduction of H2O2 production from oxidative deamination of DAP preincubated for 2 hrs fo...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLysyl oxidase homolog 2(Human)
Pharmakea Therapeutics

Curated by ChEMBL
LigandPNGBDBM50266794(CHEMBL4093765)
Affinity DataIC50: 110nMAssay Description:Inhibition of human LOXL2 expressed in CHO cells assessed as reduction of H2O2 production from oxidative deamination of DAP preincubated for 2 hrs fo...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLysyl oxidase homolog 2(Rat)
Pharmakea Therapeutics

Curated by ChEMBL
LigandPNGBDBM50266786(CHEMBL4063337)
Affinity DataIC50: 120nMAssay Description:Inhibition of rat LOXL2 expressed in CHO cells assessed as reduction of H2O2 production from oxidative deamination of DAP preincubated for 2 hrs foll...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLysyl oxidase homolog 2(Human)
Pharmakea Therapeutics

Curated by ChEMBL
LigandPNGBDBM50266785(CHEMBL4066192 | US11358936, Compound 1-41)
Affinity DataIC50: 120nMAssay Description:Inhibition of human LOXL2 expressed in CHO cells assessed as reduction of H2O2 production from oxidative deamination of DAP preincubated for 2 hrs fo...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLysyl oxidase homolog 2(Human)
Pharmakea Therapeutics

Curated by ChEMBL
LigandPNGBDBM50266783(CHEMBL4086010)
Affinity DataIC50: 130nMAssay Description:Inhibition of human LOXL2 expressed in CHO cells assessed as reduction of H2O2 production from oxidative deamination of DAP preincubated for 2 hrs fo...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLysyl oxidase homolog 2(Human)
Pharmakea Therapeutics

Curated by ChEMBL
LigandPNGBDBM50266789(CHEMBL4088453)
Affinity DataIC50: 130nMAssay Description:Inhibition of human LOXL2 expressed in CHO cells assessed as reduction of H2O2 production from oxidative deamination of DAP preincubated for 2 hrs fo...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLysyl oxidase homolog 2(Human)
Pharmakea Therapeutics

Curated by ChEMBL
LigandPNGBDBM50266783(CHEMBL4086010)
Affinity DataIC50: 130nMAssay Description:Inhibition of human LOXL2 expressed in CHO cells assessed as reduction of H2O2 production from oxidative deamination of DAP preincubated for 2 hrs fo...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLysyl oxidase homolog 2(Human)
Pharmakea Therapeutics

Curated by ChEMBL
LigandPNGBDBM50266821(CHEMBL4087273 | US11072585, Example 34)
Affinity DataIC50: 130nMAssay Description:Inhibition of human LOXL2 expressed in CHO cells assessed as reduction of H2O2 production from oxidative deamination of DAP preincubated for 2 hrs fo...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLysyl oxidase homolog 2(Human)
Pharmakea Therapeutics

Curated by ChEMBL
LigandPNGBDBM50266826(CHEMBL4105137)
Affinity DataIC50: 140nMAssay Description:Inhibition of human LOXL2 expressed in CHO cells assessed as reduction of H2O2 production from oxidative deamination of DAP preincubated for 2 hrs fo...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLysyl oxidase homolog 2(Human)
Pharmakea Therapeutics

Curated by ChEMBL
LigandPNGBDBM50266839(CHEMBL4071963)
Affinity DataIC50: 150nMAssay Description:Inhibition of human LOXL2 expressed in CHO cells assessed as reduction of H2O2 production from oxidative deamination of DAP preincubated for 2 hrs fo...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLysyl oxidase homolog 2(Human)
Pharmakea Therapeutics

Curated by ChEMBL
LigandPNGBDBM50266821(CHEMBL4087273 | US11072585, Example 34)
Affinity DataIC50: 160nMAssay Description:Inhibition of human LOXL2 expressed in CHO cells assessed as reduction of H2O2 production from oxidative deamination of DAP preincubated for 2 hrs fo...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLysyl oxidase homolog 2(Human)
Pharmakea Therapeutics

Curated by ChEMBL
LigandPNGBDBM50266825(CHEMBL4085053)
Affinity DataIC50: 180nMAssay Description:Inhibition of human LOXL2 expressed in CHO cells assessed as reduction of H2O2 production from oxidative deamination of DAP preincubated for 2 hrs fo...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLysyl oxidase homolog 2(Human)
Pharmakea Therapeutics

Curated by ChEMBL
LigandPNGBDBM50232678(CHEBI:27413 | CHEMBL1618272 | US10717734, Compound...)
Affinity DataIC50: 240nMAssay Description:Inhibition of human LOXL2 expressed in CHO cells assessed as reduction of H2O2 production from oxidative deamination of DAP preincubated for 15 mins ...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLysyl oxidase homolog 2(Human)
Pharmakea Therapeutics

Curated by ChEMBL
LigandPNGBDBM50266790(CHEMBL4096173)
Affinity DataIC50: 270nMAssay Description:Inhibition of human LOXL2 expressed in CHO cells assessed as reduction of H2O2 production from oxidative deamination of DAP preincubated for 2 hrs fo...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLysyl oxidase homolog 2(Human)
Pharmakea Therapeutics

Curated by ChEMBL
LigandPNGBDBM50266840(CHEMBL4089707 | US11072585, Example 56)
Affinity DataIC50: 270nMAssay Description:Inhibition of human LOXL2 expressed in CHO cells assessed as reduction of H2O2 production from oxidative deamination of DAP preincubated for 2 hrs fo...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLysyl oxidase homolog 2(Human)
Pharmakea Therapeutics

Curated by ChEMBL
LigandPNGBDBM50266824(CHEMBL4082808)
Affinity DataIC50: 280nMAssay Description:Inhibition of recombinant human LOXL2 expressed in human whole blood assessed as reduction of H2O2 production from oxidative deamination of DAP prein...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLysyl oxidase homolog 2(Human)
Pharmakea Therapeutics

Curated by ChEMBL
LigandPNGBDBM50266793(CHEMBL4078119)
Affinity DataIC50: 290nMAssay Description:Inhibition of human LOXL2 expressed in CHO cells assessed as reduction of H2O2 production from oxidative deamination of DAP preincubated for 2 hrs fo...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLysyl oxidase homolog 2(Human)
Pharmakea Therapeutics

Curated by ChEMBL
LigandPNGBDBM50266795(CHEMBL4063420)
Affinity DataIC50: 300nMAssay Description:Inhibition of human LOXL2 expressed in CHO cells assessed as reduction of H2O2 production from oxidative deamination of DAP preincubated for 2 hrs fo...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLysyl oxidase homolog 2(Human)
Pharmakea Therapeutics

Curated by ChEMBL
LigandPNGBDBM50232682(CHEMBL3467241 | US11358936, Compound 2-7)
Affinity DataIC50: 310nMAssay Description:Inhibition of human LOXL2 expressed in CHO cells assessed as reduction of H2O2 production from oxidative deamination of DAP preincubated for 2 hrs fo...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLysyl oxidase homolog 2(Human)
Pharmakea Therapeutics

Curated by ChEMBL
LigandPNGBDBM50232682(CHEMBL3467241 | US11358936, Compound 2-7)
Affinity DataIC50: 310nMAssay Description:Inhibition of human LOXL2 expressed in CHO cells assessed as reduction of H2O2 production from oxidative deamination of DAP preincubated for 2 hrs fo...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
Displayed 1 to 50 (of 132 total ) | Next | Last >>
Jump to: